-transparent.png){kind=logo}
Using a sonicated dispersion of radiolabeled 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine as substrate, we found that phospholipase A2 activity of human platelets was enhanced 2.4-fold by albumin (1 mg/ml). The enzyme was recovered predominantly in the cytosolic fraction of platelets with less than a third of its activity being associated with the membrane fraction. In the presence of 24 mM n-octyl-beta-D-glucopyranoside (octylglucoside) phospholipase A2 was effectively (more than 90%) extracted from platelet lysates without solubilization of platelet membranes. Ion exchange chromatography of the soluble enzyme yielded a phospholipase A2 of unchanged total activity and great stability. This phospholipase A2 was active only in the presence of divalent cations (Ca2+ greater than Sr2+ greater than Mg2+ = 0), required albumin for optimal activity and exhibited exclusive positional specificity for the acyl ester bond at the 2-position of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine. Indomethacin (500 microM), mepacrine (500 microM) and N-ethylmaleimide (4 mM) inhibited the phospholipase A2 by 69, 62 and 19%, respectively. The results are discussed in the light of previous findings on human platelet phospholipase A2.
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
January 1978,
Advances in prostaglandin and thromboxane research,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
September 1979,
Biochemical and biophysical research communications,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
May 1997,
Biochemical pharmacology,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
April 1989,
General physiology and biophysics,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
April 1991,
Biochemical and biophysical research communications,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
July 1999,
The Journal of biological chemistry,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
December 2006,
The Journal of biological chemistry,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
February 1998,
British journal of haematology,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
March 1986,
The Journal of biological chemistry,
R M Kramer, and
G C Checani, and
A Deykin, and
C R Pritzker, and
D Deykin
January 1978,
Advances in prostaglandin and thromboxane research,
